These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13763453)

  • 41. The effects of left ventricular bypass on experimental cardiogenic shock induced by electrical fibrillation or by coronary artery ligations.
    Järvinen A; Merikallio E; Aalto-Setälä M
    Ann Chir Gynaecol Fenn; 1974; 63(4):284-91. PubMed ID: 4416239
    [No Abstract]   [Full Text] [Related]  

  • 42. INFLUENCE OF THE CARDIAC NERVES ON CORONARY RESISTANCE.
    BERNE RM; DEGEEST H; LEVY MN
    Am J Physiol; 1965 Apr; 208():763-9. PubMed ID: 14274810
    [No Abstract]   [Full Text] [Related]  

  • 43. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of coronary vasodilatation on cardiac performance during endotoxin shock.
    Peyton MD; Hinshaw LB; Greenfield LJ; Elkins RC
    Surg Gynecol Obstet; 1976 Oct; 143(4):533-8. PubMed ID: 959969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [VENTRICULAR FIBRILLATION CAUSED BY ROENTGEN CONTRAST MEDIUM. (ANIMAL EXPERIMENTAL STUDY ON THE CARDIOTOXICITY)].
    PORSTMANN W
    Fortschr Geb Rontgenstr Nuklearmed; 1965 Jan; 102():36-42. PubMed ID: 14271248
    [No Abstract]   [Full Text] [Related]  

  • 46. FAILURE OF GLUCOSE-INSULIN-POTASSIUM INFUSION TO MODIFY THE CONSEQUENCES OF ACUTE CORONARY ARTERY LIGATION.
    DIXON S; HYDE S; LEONARD RP; SCHLANT RC
    J Thorac Cardiovasc Surg; 1965 May; 49():762-6. PubMed ID: 14277496
    [No Abstract]   [Full Text] [Related]  

  • 47. Coronary vasodilator properties of ethyl adenosine 5-carboxylate hydrochloride (Abbott-40557).
    Somani P
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():413-20. PubMed ID: 1226452
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of experimental hypothyroidism on coronary blood flow and hemodynamic factors.
    SCOTT JC; BALOURDAS TA; CROLL MN
    Am J Cardiol; 1961 May; 7():690-3. PubMed ID: 13749361
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
    Laubie M; Schmitt H
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.
    Koyama T; Nakagawa K; Marutani Y
    Arzneimittelforschung; 1972 Mar; 22(3):502-7. PubMed ID: 4402602
    [No Abstract]   [Full Text] [Related]  

  • 51. [EFFECTS OF PHENELZINE ON CORONARY HEMODYNAMICS IN DOGS].
    LI HY; CHEN H; TING KS
    Sheng Li Xue Bao; 1964 Mar; 27():59-66. PubMed ID: 14184588
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 53. The relation of cardiac effort to myocardial oxygen consumption and coronary flow.
    KATZ LN; FEINBERG H
    Circ Res; 1958 Sep; 6(5):656-69. PubMed ID: 13573596
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
    Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
    Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
    [No Abstract]   [Full Text] [Related]  

  • 55. IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION.
    MELVILLE KI; SHISTER HE; HUQ S
    Can Med Assoc J; 1964 Mar; 90(13):761-70. PubMed ID: 14132168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of coronary blood flow.
    BING RJ
    Methods Med Res; 1960; 8():269-75. PubMed ID: 13800774
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of 4-[5-amino-3-(4-pyridyl)-1-pyrazolyl] -1-methyl-piperidine hydrochloride upon the general and coronary hemodynamics of the intact animal.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):373-8. PubMed ID: 5954036
    [No Abstract]   [Full Text] [Related]  

  • 58. EFFECT OF ANGIOTENSIN UPON CORONARY FLOW AND OXYGEN CONSUMPTION OF THE ISOLATED HEART OF THE CAT.
    DOUGLAS CR; PONCE-ZUMINO A; RUIZ-PETRICH E; PUIG F; TALESNIK J
    Acta Physiol Lat Am; 1964; 14():161-9. PubMed ID: 14185506
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
    Kraupp O; Grossmann W; Stühlinger W; Raberger G
    Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of the substitute fluids on hyperemic ventricular fibrillation in the dog. V].
    Wojtowicz M; Dybicki J; Wrzolek S; Bartoszewicz T
    Pol Arch Med Wewn; 1966; 36(6):843-6. PubMed ID: 5911411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.